Location History:
- Hoor, SE (1992 - 2006)
- Höör, SE (2006 - 2010)
- Lund, SE (2013 - 2015)
Company Filing History:
Years Active: 1992-2015
Title: **Stefan Andersson-Engels: A Pioneer in Luminescent Imaging and Photodynamic Therapy**
Introduction
Stefan Andersson-Engels is a distinguished inventor based in Lund, Sweden. With a remarkable portfolio of 8 patents, he has significantly contributed to the fields of luminescent imaging and photodynamic therapy. His innovations reflect a commitment to advancing medical technologies, enhancing diagnostic capabilities, and improving patient outcomes.
Latest Patents
Among his recent patents, one noteworthy invention is the "System, method, and luminescent marker for improved diffuse luminescent imaging or tomography in scattering media." This invention provides a method and system for molecular imaging, improving the contrast and resolution in imaging or tomographic processes within scattering mediums. By utilizing a non-linear luminescent marker, which can upconvert incoming light, this system enhances imaging precision through the simultaneous use of multiple excitation beams.
Another recent patent is the "System and method for controlling and adjusting interstitial photodynamic light therapy parameters." This invention focuses on optimizing light control during interstitial tumor photodynamic light therapy by employing a calculation method to assess tissue status throughout treatment. It ensures effective PDT by adapting delivery methods based on real-time tissue responses, ultimately minimizing patient undertreatment and the risk of damage to healthy surrounding organs.
Career Highlights
Stefan Andersson-Engels has had a profound impact on the healthcare technology industry, particularly during his time with major companies such as AstraZeneca and SpectraCure. His work has been pivotal in the development of groundbreaking technologies that integrate science and innovation, thereby fostering advancements in therapeutic practices.
Collaborations
Throughout his career, Stefan has collaborated with esteemed colleagues, including Sune Svanberg and Jonas Johansson. These partnerships have facilitated knowledge exchange and collaborative research, further driving innovation in their shared fields of expertise.
Conclusion
Stefan Andersson-Engels’ contributions to luminescent imaging and photodynamic therapy exemplify the essence of innovation in healthcare technology. With a strong foundation in research and collaboration, his patents are not just inventions; they represent significant strides towards enhanced diagnostic techniques and therapeutic interventions. As he continues his work, the medical community can look forward to more groundbreaking advancements that will redefine patient care.